Limits on federal pot prosecution just got a brief extension, but medical marijuana may still be at risk
UPDATE: Congress gave the Rohrabacher-Blumenauer amendment a temporary reprieve after this piece was originally published, extending protections until Dec. 22. Rep. Earl Blumenauer, D-Ore., responded by saying, “[T]wo weeks is not enough certainty,” and adding, “Congress must act to put an end to the cycle of uncertainty and permanently protect state medical marijuana programs — and adult use — from federal interference.”
In all the budget and tax negotiations frantically being hammered out on Capitol Hill, one small amendment that might get lost in the shuffle could have huge ramifications. The Rohrabacher-Blumenauer amendment was originally set to expire on Friday (see update above), which would open the door for Attorney General Jeff Sessions to do what he’s been hinting he wants to: Launch a federal war on states that have partly or completely legalized marijuana use.
The Rohrabacher-Blumenauer amendment, originally passed as the the Rohrabacher-Farr amendment in 2014, bars the Department of Justice from using federal funds to prosecute people buying or selling medical marijuana in states that have legalized it. It’s a popular bipartisan amendment that protects 46 states, but there have been concerns about whether it will be renewed after Sessions exerted pressure in May on Congress to let the amendment die.
Sessions argued that the DOJ’s hands need to be untied when it comes to prosecuting marijuana dispensaries, “particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime.” There is, of course, no evidence that marijuana use is contributing to the opioid crisis and, in fact, there’s a significant link between legalized medical marijuana and a decrease in opioid overdoses.
The amendment survived, despite Sessions’ pressure, through a couple rounds of budget debate in Congress this year, but as Ames Grawert of the Brennan Center for Justice told Salon, “Every time, there’s sort of a dance around whether it will actually get cut this time or not.” It’s reasonable to be at least “a little concerned,” Grawert said, that Sessions’ pressure will eventually convince congressional Republicans to dump the amendment.
This will-they-or-won’t-they game is why Rep. Dana Rohrabacher, a California Republican, and a bipartisan group of 24 other lawmakers have introduced the Respect State Marijuana Laws Act of 2017, which would prevent the federal government from prosecuting any marijuana users, growers or distributors who are in compliance with state laws.
“You have booming economies in several states, some of whom allow the recreational use of marijuana but many also just for medical purposes, and no real data linking that to a public safety problem,” Grawert said, noting that the Brennan Center objects to using federal resources to prosecute people or break up thriving economies without any data to show that doing so would improve public safety.
In March, Sessions argued that marijuana use is “only slightly less awful” than heroin addiction, making it clear that his priority was to aggressively prosecute marijuana users and distributors. He’s been stymied by both the Rohrabacher-Blumenauer amendment and a memo issued by then-Deputy Attorney General James Cole that discouraged the Justice Department from prosecuting people who were following state-level marijuana laws. The obvious concern here, however, is that Sessions would seize upon the first political opening available to reinvigorate the federal war on pot.